JP2005523316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005523316A5 JP2005523316A5 JP2003585725A JP2003585725A JP2005523316A5 JP 2005523316 A5 JP2005523316 A5 JP 2005523316A5 JP 2003585725 A JP2003585725 A JP 2003585725A JP 2003585725 A JP2003585725 A JP 2003585725A JP 2005523316 A5 JP2005523316 A5 JP 2005523316A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- patient eye
- product
- effective amount
- intraocular pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 17
- 230000004410 intraocular pressure Effects 0.000 claims 8
- 208000010412 Glaucoma Diseases 0.000 claims 7
- 229960000686 benzalkonium chloride Drugs 0.000 claims 7
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims 7
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 claims 6
- XYLJNLCSTIOKRM-UHFFFAOYSA-N Alphagan Chemical compound C1=CC2=NC=CN=C2C(Br)=C1NC1=NCCN1 XYLJNLCSTIOKRM-UHFFFAOYSA-N 0.000 claims 6
- 229960003679 brimonidine Drugs 0.000 claims 6
- 229960004605 timolol Drugs 0.000 claims 6
- 238000011200 topical administration Methods 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- 239000005022 packaging material Substances 0.000 claims 3
- 206010030043 Ocular hypertension Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/126,790 US7030149B2 (en) | 2002-04-19 | 2002-04-19 | Combination of brimonidine timolol for topical ophthalmic use |
| PCT/US2003/010885 WO2003088973A1 (en) | 2002-04-19 | 2003-04-09 | Combination of brimonidine and timolol for topical ophthalmic use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005523316A JP2005523316A (ja) | 2005-08-04 |
| JP2005523316A5 true JP2005523316A5 (https=) | 2006-01-05 |
Family
ID=29215107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003585725A Pending JP2005523316A (ja) | 2002-04-19 | 2003-04-09 | 眼科局所用のブリモニジンとチモロールとの組み合わせ |
Country Status (17)
| Country | Link |
|---|---|
| US (16) | US7030149B2 (https=) |
| EP (2) | EP2241319A1 (https=) |
| JP (1) | JP2005523316A (https=) |
| KR (1) | KR100723189B1 (https=) |
| CN (2) | CN101664414A (https=) |
| BR (1) | BR0302584A (https=) |
| CA (1) | CA2440764C (https=) |
| CY (1) | CY1114048T1 (https=) |
| DK (1) | DK1496912T3 (https=) |
| ES (1) | ES2399045T3 (https=) |
| MX (2) | MXPA03008401A (https=) |
| NO (1) | NO326579B1 (https=) |
| NZ (1) | NZ528945A (https=) |
| PT (1) | PT1496912E (https=) |
| SI (1) | SI1496912T1 (https=) |
| TW (1) | TWI351959B (https=) |
| WO (1) | WO2003088973A1 (https=) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050026924A1 (en) * | 2000-07-14 | 2005-02-03 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
| US7030149B2 (en) | 2002-04-19 | 2006-04-18 | Allergan, Inc. | Combination of brimonidine timolol for topical ophthalmic use |
| US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
| CN100413503C (zh) * | 2005-01-07 | 2008-08-27 | 冷文 | 一种复方眼药组合物 |
| US7534795B2 (en) * | 2005-10-25 | 2009-05-19 | Allergan, Inc. | Compounds and their use related to compositions for treating disease |
| US20070238732A1 (en) * | 2006-04-10 | 2007-10-11 | Allergan, Inc. | Brimonidine and timolol compositions |
| WO2008024846A2 (en) * | 2006-08-25 | 2008-02-28 | Allergan, Inc. | Brimonidine and timolol compositions |
| US20080051406A1 (en) * | 2006-08-25 | 2008-02-28 | Richard Graham | Brimonidine and timolol compositions |
| MX2007010025A (es) * | 2007-08-17 | 2009-02-25 | Arturo Jimenez Bayardo | Composición farmacéutica para tratamiento de hipertensión ocular. |
| MX2007011165A (es) * | 2007-09-12 | 2009-03-11 | Arturo Jimenez Bayardo | Composición farmacéutica estable de timolol, dorzolamida y brimonidina. |
| US20100203165A1 (en) | 2008-08-01 | 2010-08-12 | Gerald Horn | Compositions and methods for treatment of disorders or conditions of the eye |
| US12246013B2 (en) | 2008-08-01 | 2025-03-11 | Eye Therapies Llc | Vasoconstriction compositions and methods of use |
| US8952011B2 (en) | 2008-08-01 | 2015-02-10 | Eye Therapies Llc | Compositions and methods for the treatment of nasal conditions |
| US20100028266A1 (en) | 2008-08-01 | 2010-02-04 | Alpha Synergy Development. Inc. | Composition and methods for treating allergic response |
| JP5218167B2 (ja) | 2009-03-11 | 2013-06-26 | 日立電線株式会社 | コネクタ |
| US8299079B2 (en) | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| WO2010135731A1 (en) * | 2009-05-22 | 2010-11-25 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| US8987270B2 (en) | 2009-07-27 | 2015-03-24 | Eye Therapies Llc | Formulations of selective alpha-2 agonists and methods of use thereof |
| US8317973B2 (en) | 2009-11-11 | 2012-11-27 | Kemira Chemical, Inc. | Polyester surfactants for deinking |
| US20110152271A1 (en) * | 2009-12-17 | 2011-06-23 | Gerald Horn | Compositions and methods for ophthalmic delivery of nasal decongestants |
| MX2012007397A (es) * | 2009-12-22 | 2012-08-15 | Allergan Inc | Composiciones y metodos para reducir la presion intraocular. |
| US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
| HUE040283T2 (hu) | 2010-07-29 | 2019-02-28 | Allergan Inc | Brimonidin és timolol tartalmú, tartósítószer-mentes oldatok |
| US8445526B2 (en) | 2011-02-03 | 2013-05-21 | Glaucoma & Nasal Therapies Llc | Compositions and methods for treatment of glaucoma |
| US9283217B2 (en) | 2011-11-10 | 2016-03-15 | Allergan, Inc. | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
| UA109359C2 (xx) * | 2011-11-10 | 2015-08-10 | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
| KR20140103168A (ko) * | 2011-12-16 | 2014-08-25 | 알러간, 인코포레이티드 | 폴리비닐 카프라락탐-폴리비닐 아세테이트-폴리에틸렌 글리콜 그라프트 코폴리머를 포함하는 안과 조성물 |
| US8999938B2 (en) | 2013-06-21 | 2015-04-07 | Gnt Llc | Ophthalmic lipophilic drug delivery vehicle formulations |
| KR20170129823A (ko) * | 2015-03-19 | 2017-11-27 | 알러간, 인코포레이티드 | 브리모니딘 및 티몰롤의 고정된 용량 조합 |
| MX2019001633A (es) | 2016-08-12 | 2019-09-18 | Silk Tech Ltd | Proteina derivada de la seda para el tratamiento de la inflamacion. |
| WO2018033854A1 (en) | 2016-08-15 | 2018-02-22 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition and a method for treating ocular hypertension and glaucoma |
| EP3576770A1 (en) * | 2017-02-01 | 2019-12-11 | Shire Human Genetic Therapies, Inc. | Compounds and compositions for the treatment of ophthalmic disorders |
| RS67824B1 (sr) * | 2017-06-08 | 2026-03-31 | Eye Therapies Llc | Oftalmološke kompozicije koje sadrže brimonidin i ketotifen za upotrebu u lečenju alergija |
| US20200108064A1 (en) * | 2017-06-08 | 2020-04-09 | Eye Therapies, Llc | Low-dose brimonidine combinations and uses thereof |
| CN111132640B (zh) * | 2017-09-25 | 2023-01-10 | 佛罗里达大学研究基金会股份有限公司 | 从含亲水药物的滴眼剂中除去防腐剂 |
| US20190134051A1 (en) * | 2017-11-06 | 2019-05-09 | Rheostasis, Llc | Composition for treating ocular disorders such as macular degeneration, retinopathy and glaucoma |
| KR102882058B1 (ko) | 2018-03-28 | 2025-11-07 | 노바리크 게엠베하 | 티몰롤을 포함하는 약제학적 조성물 |
| US11871308B2 (en) * | 2019-07-29 | 2024-01-09 | TapText llc | System and method for link-initiated dynamic-mode communications |
| EP4057941A4 (en) | 2019-11-15 | 2024-05-29 | Silk Technologies Ltd. | Stable formulations of silk-derived protein |
| MX2022007389A (es) | 2019-12-19 | 2022-08-10 | Tearclear Corp | Remocion del conservante de las gotas para los ojos. |
| CN120617269A (zh) * | 2025-06-16 | 2025-09-12 | 鲁南贝特制药有限公司 | 一种溴莫尼定噻吗洛尔滴眼液及其制备方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4029792A (en) * | 1972-02-29 | 1977-06-14 | Pfizer Inc. | (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents |
| BE795970A (fr) | 1972-02-29 | 1973-08-27 | Pfizer | Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant |
| US4195085A (en) | 1975-09-26 | 1980-03-25 | Merck & Co., Inc. | Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| CA1325382C (en) * | 1988-01-27 | 1993-12-21 | Takahiro Ogawa | Locally administrable therapeutic composition for inflammatory disease |
| CA1334168C (en) | 1988-04-26 | 1995-01-31 | Louis M. De Santis | Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers |
| CA2003198C (en) * | 1988-11-29 | 1995-03-21 | Anthony J. Dziabo, Jr. | Aqueous ophthalmic solutions and method for preserving same |
| US5021410A (en) * | 1989-05-22 | 1991-06-04 | Allergan, Inc. | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
| US5021416A (en) | 1989-10-31 | 1991-06-04 | Allergan, Inc. | Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure |
| US5215991A (en) * | 1990-01-26 | 1993-06-01 | Allergan, Inc. | Combination of selective alpha-adrenergic agonists and Na+ /H+ ex |
| DE4201079C3 (de) | 1992-01-17 | 1997-09-11 | Gramer Eugen | Kombinationspräparate zur Augeninnendrucksenkung |
| US5290781A (en) * | 1993-01-05 | 1994-03-01 | Iolab Corporation | Ketaneserinol as an agent to reduce intraocular pressure |
| TW354762B (en) * | 1993-02-23 | 1999-03-21 | Otsuka Pharma Co Ltd | Agent for prophylaxis or treatment of cataract |
| SK77396A3 (en) | 1993-12-17 | 1997-01-08 | Procter & Gamble | 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| US5440505A (en) * | 1994-01-21 | 1995-08-08 | Intel Corporation | Method and circuitry for storing discrete amounts of charge in a single memory element |
| SE9401109D0 (sv) * | 1994-03-31 | 1994-03-31 | Leiras Oy | Opthalmic composition II |
| US5564596A (en) * | 1994-05-05 | 1996-10-15 | Allergan, Inc. | Multiple fluid dispensing device for low surface tension formulations |
| US6294563B1 (en) * | 1994-10-27 | 2001-09-25 | Allergan Sales, Inc. | Combinations of prostaglandins and brimonidine or derivatives thereof |
| US6194415B1 (en) | 1995-06-28 | 2001-02-27 | Allergan Sales, Inc. | Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
| US5856329A (en) | 1995-06-28 | 1999-01-05 | Allergan | Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| US6441047B2 (en) * | 1995-11-17 | 2002-08-27 | Alcon Manufacturing Ltd.. | Combination therapy for treating glaucoma |
| EP1057486A1 (en) * | 1995-11-17 | 2000-12-06 | Alcon Laboratories, Inc. | Use of drug combination for treating Glaucoma |
| US6159458A (en) * | 1997-11-04 | 2000-12-12 | Insite Vision | Sustained release ophthalmic compositions containing water soluble medicaments |
| EP1069913B1 (en) * | 1998-04-07 | 2003-07-23 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
| US6174524B1 (en) * | 1999-03-26 | 2001-01-16 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
| US6440964B1 (en) * | 1998-09-30 | 2002-08-27 | Alcon Manufacturing, Ltd. | Compositions and methods for treating ophthalmic and otic infections |
| US6740664B2 (en) * | 1998-09-30 | 2004-05-25 | Alcon, Inc. | Methods for treating otic and ophthalmic infections |
| US6146622A (en) * | 1998-10-27 | 2000-11-14 | Alcon Laboratories, Inc. | Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions |
| US6242442B1 (en) * | 1998-12-17 | 2001-06-05 | Alcon Laboratories, Inc. | Brinzolamide and brimonidine for treating ocular conditions |
| US6410045B1 (en) * | 1999-02-22 | 2002-06-25 | Clyde Lewis Schultz | Drug delivery system for antiglaucomatous medication |
| WO2002005848A2 (en) * | 2000-07-13 | 2002-01-24 | Pharmacia Corporation | Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| CA2416169C (en) * | 2000-07-14 | 2008-09-23 | Allergan, Inc. | Compositions containing therapeutically active components having enhanced solubility |
| PL360707A1 (en) * | 2000-07-14 | 2004-09-20 | Allergan Inc. | Compositions containing alpha-2-adrenergic agonist components |
| TWI292914B (https=) * | 2002-01-17 | 2008-01-21 | Macronix Int Co Ltd | |
| US7030149B2 (en) | 2002-04-19 | 2006-04-18 | Allergan, Inc. | Combination of brimonidine timolol for topical ophthalmic use |
| US7642258B2 (en) * | 2002-04-19 | 2010-01-05 | Allergan, Inc. | Combination of brimonidine and timolol for topical ophthalmic use |
| KR100521364B1 (ko) * | 2002-11-18 | 2005-10-12 | 삼성전자주식회사 | 플레쉬 메모리 셀들의 프로그램 오판을 방지하고 균일한문턱 전압 산포를 가질 수 있는 플레쉬 메모리 장치 및 그프로그램 검증 방법 |
-
2002
- 2002-04-19 US US10/126,790 patent/US7030149B2/en not_active Expired - Lifetime
-
2003
- 2003-02-03 US US10/357,622 patent/US7323463B2/en not_active Expired - Lifetime
- 2003-04-09 EP EP20100171064 patent/EP2241319A1/en not_active Ceased
- 2003-04-09 NZ NZ528945A patent/NZ528945A/en not_active IP Right Cessation
- 2003-04-09 SI SI200332241T patent/SI1496912T1/sl unknown
- 2003-04-09 MX MXPA03008401A patent/MXPA03008401A/es active IP Right Grant
- 2003-04-09 PT PT37262342T patent/PT1496912E/pt unknown
- 2003-04-09 CA CA002440764A patent/CA2440764C/en not_active Expired - Lifetime
- 2003-04-09 JP JP2003585725A patent/JP2005523316A/ja active Pending
- 2003-04-09 KR KR1020037015881A patent/KR100723189B1/ko not_active Ceased
- 2003-04-09 CN CN200910174400A patent/CN101664414A/zh active Pending
- 2003-04-09 MX MX2014003586A patent/MX368377B/es unknown
- 2003-04-09 ES ES03726234T patent/ES2399045T3/es not_active Expired - Lifetime
- 2003-04-09 EP EP03726234.2A patent/EP1496912B9/en not_active Revoked
- 2003-04-09 DK DK03726234.2T patent/DK1496912T3/da active
- 2003-04-09 BR BR0302584-5A patent/BR0302584A/pt not_active Application Discontinuation
- 2003-04-09 WO PCT/US2003/010885 patent/WO2003088973A1/en not_active Ceased
- 2003-04-09 CN CNB038004682A patent/CN100558364C/zh not_active Expired - Lifetime
- 2003-04-18 TW TW092109050A patent/TWI351959B/zh not_active IP Right Cessation
- 2003-10-14 US US10/685,941 patent/US7320976B2/en not_active Expired - Lifetime
-
2004
- 2004-10-19 NO NO20044450A patent/NO326579B1/no not_active IP Right Cessation
-
2007
- 2007-11-28 US US11/946,828 patent/US8133890B2/en not_active Expired - Fee Related
-
2011
- 2011-11-30 US US13/308,507 patent/US8354409B2/en not_active Expired - Fee Related
-
2012
- 2012-12-26 US US13/727,106 patent/US20130116255A1/en not_active Abandoned
-
2013
- 2013-03-01 CY CY20131100193T patent/CY1114048T1/el unknown
- 2013-03-13 US US13/801,252 patent/US20130196995A1/en not_active Abandoned
- 2013-08-01 US US13/957,287 patent/US8748425B2/en not_active Expired - Lifetime
-
2014
- 2014-04-28 US US14/263,740 patent/US20150087647A1/en not_active Abandoned
-
2016
- 2016-06-24 US US15/192,729 patent/US9474751B1/en not_active Expired - Fee Related
-
2017
- 2017-02-22 US US15/439,112 patent/US9770453B2/en not_active Expired - Fee Related
- 2017-08-02 US US15/667,248 patent/US20180042932A1/en not_active Abandoned
- 2017-11-02 US US15/802,179 patent/US9907801B1/en not_active Expired - Fee Related
- 2017-11-02 US US15/802,229 patent/US9907802B1/en not_active Expired - Fee Related
-
2019
- 2019-05-07 US US16/405,813 patent/US20200129520A1/en not_active Abandoned
-
2021
- 2021-02-05 US US17/168,513 patent/US20210405280A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005523316A5 (https=) | ||
| JP2006503913A5 (https=) | ||
| US20120004158A1 (en) | Quaternised Ammonium Cyclodextrin Compounds | |
| AU2011274245B2 (en) | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease | |
| CA2807084C (en) | Preservative free brimonidine and timolol solutions | |
| WO2019216381A1 (ja) | 眼科組成物 | |
| JP2021102626A5 (https=) | ||
| JP2019507758A5 (https=) | ||
| JP7787129B2 (ja) | 眼科組成物 | |
| WO2017042404A1 (es) | Composición farmacéutica de tramadol para uso oftálmico | |
| JP7348347B2 (ja) | 眼科組成物 | |
| JP2006232822A (ja) | プラノプロフェン含有組成物 | |
| JP2019006776A (ja) | 水溶性高分子を含む点眼剤 | |
| JP4718160B2 (ja) | 眼科用組成物 | |
| KR20190071674A (ko) | 안과용 제제 및 안과용 약 | |
| WO2023024126A1 (zh) | 一种含伏立康唑的眼用凝胶剂及其制备方法与应用 | |
| CN115634226B (zh) | 一种采用长春西汀治疗近视的方法 | |
| ES2974884T3 (es) | Composición de colirio para reducir la presión intraocular | |
| JP2004536847A5 (https=) | ||
| TWI896143B (zh) | 一種有效延緩及治療近視的藥物組合物 | |
| EP3681473A1 (en) | Topical formulations of chloroprocaine | |
| CN108348457A (zh) | 无菌水性眼用溶液的治疗用途 | |
| Goldberg | Comparison of tropical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J. Glaucoma 2001; 10: 414-22 | |
| CA2470866A1 (en) | Uses of dorzolamide to improve night vision | |
| HK1214536B (zh) | Lfa-1抑制剂制剂 |